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Ahmad R Hariri
1* and Lisa M Shin
2,3
We are witnessing dramatic and exciting shifts in the
very foundations of mental health and psychiatry [1-3].
At this time perhaps more than any other it is impera-
tive that research into the biological underpinnings of
psychopathology be given a proper outlet to inform,
educate and advance these processes in the service of
improving the human condition. Indeed, specialized out-
lets have been created for biological research in a num-
ber of disorders including autism, schizophrenia and
bipolar disorder [4-6]. Surprisingly, no such dedicated
outlet has been available for mood and anxiety disor-
ders, the most common forms of psychopathology, until
now.
Biology of Mood & Anxiety Disorders (BMAD) is a new
open access peer-reviewed journal that publishes highly
innovative basic, translational and clinical research that
advances our understanding of mood and anxiety disor-
ders. The journal welcomes research in all areas relevant
to the disorders at the level of their underlying mechan-
isms. Research areas of interest include but are not lim-
ited to: pathophysiology, predictive risk markers,
treatment predictors, individual differences and develop-
mental trajectories of mood and anxiety disorders.
Experimental approaches include but are not limited to:
neuroimaging, psychophysiology, behavioral and mole-
cular genetics, pharmacology, gene-environment interac-
tions, and non-human animal models.
Our idea behind BMAD is to create a venue for cut-
ting-edge research that will become the destination of
choice for the best work in the field. We are dedicated
to providing an outlet for contributions that advance the
field in any significant way. We believe that BMAD will
be an important platform for presenting the findings of
those interested in the biology of mood and anxiety dis-
orders at any and all levels. The enthusiastic response
from colleagues in neuroscience, psychology, psychiatry,
psychophysiology, pharmacology and genetics who have
graciously committed their time and expertise by joining
the Editorial Board of BMAD [7] is testament to the
value of this novel venue.
Continued progress in understanding the biology of
mood and anxiety disorders is critically dependent on
the integration of knowledge gained across many disci-
plines, methodologies and model systems; currently
such knowledge is divided across publications in many
journals, none of which is focused entirely on the biol-
ogy of mood and anxiety disorders. The Editors of
BMAD thus believe that there is a need for a dedicated
journal in this highly diverse field, and given the rising
popularity of open access publication, we thought that a
new open access journal in our field was particularly
timely.
The three publications in this inaugural issue highlight
the diversity and breadth of relevant research we seek to
encourage and promote at BMAD. Fisher and colleagues
report on a multimodal PET/fMRI study demonstrating
that the balance between excitatory 5-HT2A and inhibi-
tory 5-HT1A receptors in the medial prefrontal cortex
determines, at least in part, the functional responsive-
ness of the amygdala. These data provide unique insight
into specific molecular mechanisms through which a
common treatment target, namely 5-HT signaling, mod-
ulates a corticolimbic circuitry heavily implicated in the
pathophysiology of mood and anxiety disorders. Murphy
and Frodl present findings of altered white matter path-
ways in depression derived from a meta-analysis of dif-
fusion tensor imaging studies. Their meta-analysis
reveals specific decreases in the functional integrity of
the superior longitudinal fasciculus in patients with
major depressive disorder. Finally, Waters and McCor-
mick describe the challenges involved in examining the
effect of exogenous corticosterone on anxiety-like and
depressive behavior in adolescent rats. Such diversity
will continue to be featured in the forthcoming months,
including reviews on facial emotion processing in major
depressive disorder, evoked potential studies in post
traumatic stress disorder (PTSD), and validation criteria
in animal models of anxiety and depression, as well as
original research on the involvement of the habenula in
PTSD.
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those above to be readily accessible and far-reaching
because they will appear online and without charge to
readers for access. An online journal also means more
rapid reviews and shorter time to publication. Articles
will be published online immediately upon acceptance
and soon after listed in PubMed. For an interdisciplinary
field, dispensing new knowledge quickly is critical. A
fixed article-processing charge will be levied to cover
the publication costs; there are no additional page or
color figure charges [8]. We would like to note that
many universities are now defraying the costs of open
access publishing [9,10] furthering the accessibility of
BMAD to our community.
While the open access format will allow us to publish
articles without the constraint of page limitations, we
are pleased to provide a specific forum for Brief Reports
of less than 1500 words, which are no longer supported
by many journals in psychiatry and neuroscience. We
hope that the availability of the Brief Report format will
allow for even more rapid publication of highly novel
and influential research. Finally, the online format per-
mits the journal to generate a cover for every article we
publish. We therefore provide the opportunity for
authors of each article to highlight their work through
their chosen cover image.
The Editors of BMAD are committed to making this
new venture a success for all investigators exploring the
biological processes underlying mood and anxiety disor-
ders. We hope that you share our vision and will join us
in making the journal the primary outlet for research in
our field and an invaluable resource not only for our
scientific community but for all who share an interest in
mental health.
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